Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis.
Kumar
N
N
Division of Infectious Diseases, Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. kumar.neeraj@mayo.edu
Orenstein
R
R
Uslan
D Z
DZ
Berbari
E F
EF
Klein
C J
CJ
Windebank
A J
AJ
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007249:Inflammation / Q000139:chemically induced* / Q000188:drug therapy; D008549:Melarsoprol / Q000009:adverse effects*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced*; D014344:Trypanocidal Agents / Q000009:adverse effects*; D014353:Trypanosomiasis, African / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D014344:Trypanocidal Agents; D008775:Methylprednisolone; D008549:Melarsoprol